Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
WWE, UFC Announce $24.1 Billion Merger Deal
WWE, UFC Announce $24.1 Billion Merger Deal
Afternoon Alexa Flash Briefings of April 3rd
Afternoon Alexa Flash Briefings
Walmart Revamps Website in Bid to Boost Sales of Merchandise
Walmart on Monday announced a revamp of its website and app as it competes with e-commerce giant Amazon for online customers.
Swiss Prosecutors Probe Credit Suisse Ahead of UBS Takeover
The Swiss attorney general’s office says it has opened a probe into the events surrounding embattled bank Credit Suisse, which is to be taken over by rival UBS.
Stocks End Mixed as Jump in Oil Prices Fans Inflation Fears
Stock markets around the world are mixed Monday, as a jump in oil prices threatens to add upward pressure on inflation.
Tesla Sales Rise 36 Percent in First Quarter, Following Price Cuts
Tesla's first-quarter vehicle sales rose 36% after the company cut prices twice in a bid to stimulate demand.
WSJ: McDonald's Is Closing Offices Ahead of Layoffs
According to a Wall Street Journal report, McDonald's is closing its U.S. offices this week ahead of planned layoffs. The report cited an internal memo that told managers to stay home through the week, so they can inform employees of the layoffs virtually.
Cheddar Morning News Briefings of April 3rd
Cheddar Morning News Briefings
Morning Alexa Flash Briefings of April 3rd
Morning Alexa Flash Briefings
